{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Pfizer", "item": "https://www.patentleaderboard.com/company/pfizer"}, {"@type": "ListItem", "position": 3, "name": "Robert Vernon Stanton", "item": "https://www.patentleaderboard.com/inventor/fl:ro_ln:stanton-1"}]}

Home › Pfizer › Robert Vernon Stanton

RS

Robert Vernon Stanton — 2 Patents

Pfizer: 2 patents #2,085 of 5,153Top 45%

Belmont, MA: #661 of 1,163 inventorsTop 60%

Massachusetts: #42,563 of 88,656 inventorsTop 50%

Overall (All Time): #1,709,992 of 4,157,543Top 45%

2 Patents All Time

Robert Vernon Stanton has been granted 2 US patents while listed as an inventor at Pfizer. The first was granted in 2016 and the most recent in August 2017. Robert Vernon Stanton ranks #1,709,992 of 4,157,543 US inventors in our database (top 41.1%). Patent records list Robert Vernon Stanton in Belmont, MA, US.

Issued Patents All Time

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
9738626	Antagonists of prostaglandin EP3 receptor	Kevin Bahnck, Daniel Canterbury, David James Edmonds, Kentaro Futatsugi, Esther Cheng Yin Lee +2 more	2017-08-22	$672,498,000
9278953	Antagonists of prostaglandin EP3 receptor	Kevin Bahnck, David James Edmonds, Kentaro Futatsugi, Esther Cheng Yin Lee, Alan M. Mathiowetz +1 more	2016-03-08	$658,400,000

Robert Vernon Stanton — 2 Patents

Issued Patents All Time

Patent Widget